Anxiety disorders affect over 300 million people worldwide - an estimated 4% of the total population - making them some of the most common and debilitating mental health challenges. In recent years, interest in natural and integrative therapies has soared, with mushrooms (ranging from everyday edible and functional varieties to powerful psychedelic species) gaining attention for their potential role in easing anxiety. Advances in mycology and clinical research have started to uncover the many ways these fungi might influence anxiety, providing options that range from subtle stress relief to transformative therapeutic breakthroughs.
What are the anxiety-reducing benefits of edible and functional mushrooms?
Edible and functional mushrooms such as Lion’s Mane, Reishi, and Cordyceps have been staples in traditional medicine, particularly across Asia, for centuries. Modern science is now validating these traditional uses, revealing how these mushrooms may contribute to reducing anxiety through various biological pathways.
Lion’s Mane, for example, has been shown in recent clinical trials to promote the production of nerve growth factor (NGF), which supports brain plasticity (the brain’s ability to form new neural connections). This neuroplasticity is crucial for improving mood regulation and cognitive resilience, both important for managing anxiety. Studies from 2022 to 2025 highlight how regular supplementation with Lion’s Mane can lead to noticeable reductions in anxiety and depressive symptoms.
Reishi mushrooms are recognized for their adaptogenic qualities, meaning they help the body manage stress more effectively. Research indicates that Reishi modulates the hypothalamic-pituitary-adrenal (HPA) axis, which controls the body’s stress response. By reducing the stress hormone cortisol, Reishi may help lower anxiety levels, particularly in individuals facing chronic stress. Cordyceps, though less studied directly for anxiety, improves mitochondrial function and energy metabolism, which can combat fatigue—a common contributor to anxiety symptoms.
These mushrooms are generally consumed as teas, tinctures, or capsules, and while their effects tend to be gentle and cumulative, they offer promising support for those seeking natural anxiety relief without the side-effects of prescription anxiety medications.
How does psilocybin affect anxiety and what does current research show?
Psilocybin, the psychoactive compound found in “magic” mushrooms, has rapidly shifted from the fringes of scientific research to the cutting edge of psychiatric treatment. Initially studied primarily for depression and PTSD, recent investigations have illuminated its potential in treating various anxiety disorders, including generalized anxiety disorder (GAD), social anxiety, and anxiety linked to serious medical conditions.
One of the most compelling areas of psilocybin research is its use in alleviating anxiety in patients with life-threatening illnesses like cancer. A landmark 2023 study published in JAMA Psychiatry demonstrated that just two sessions of psilocybin-assisted therapy led to rapid and sustained reductions in anxiety and depression among patients with advanced cancer, with effects lasting up to a year after treatment. This suggests that psilocybin can foster deep psychological healing beyond simply masking symptoms.
Mushrooms containing psilocybin growing in a plastic bin
Additionally, early clinical trials from 2024 point to psilocybin’s effectiveness in easing symptoms of generalized anxiety disorder. The treatment seems to work by facilitating emotional breakthroughs and helping patients develop a new relationship with anxiety—often characterized by greater acceptance and less fear of uncertainty, which are core issues in anxiety disorders.
At the neurobiological level, psilocybin acts primarily on serotonin 2A receptors in the brain, temporarily disrupting rigid patterns of negative thinking. This “reset” allows patients to disengage from chronic worry and cognitive loops that fuel anxiety, enabling lasting changes in perception and emotional processing. Although psilocybin therapy remains regulated and should only be pursued under professional supervision, it holds promise especially for those whose anxiety has been resistant to conventional treatments.
How do mushrooms biologically support anxiety relief?
Across different types of mushrooms, several biological mechanisms may explain their anxiety-reducing effects. Both functional and psychedelic mushrooms promote neuroplasticity, encouraging the brain to form new connections and pathways that support healthier emotional regulation. This flexibility is crucial for overcoming the rigid, repetitive thought patterns typical of anxiety.
Many mushroom species also contain bioactive compounds that exhibit anti-inflammatory properties, like beta-glucans and triterpenoids. Chronic inflammation has been increasingly linked to anxiety and other mental health disorders, so reducing inflammation may help alleviate symptoms.
As mentioned previously, functional mushrooms such as Reishi appear to help modulate the HPA axis, preventing excessive cortisol release that contributes to anxiety and its physical effects.
Finally, the emerging science around the gut-brain axis points to mushrooms’ influence on the gut microbiome as another way they may improve anxiety. Since gut health is closely tied to mood regulation, supporting a balanced microbiome through mushroom consumption could be a valuable piece of anxiety management.
What should you know about integrating mushrooms into anxiety treatment?
For those considering mushrooms as part of their anxiety care, expert guidance emphasizes caution and gradual integration. While many people notice effects from functional mushrooms after their first use, the real benefits come with consistent use over time. Taken regularly over weeks or months, they offer gentle, lasting support for overall well-being.
Psilocybin therapy, on the other hand, is a highly controlled intervention that must be conducted under medical supervision within legal frameworks. Preparation, mindset, and careful post-session integration are critical for ensuring safety and maximizing therapeutic outcomes.
Additionally, it’s important to be aware of potential interactions between mushrooms and medications, especially antidepressants like SSRIs or immune system modulators. Consulting healthcare providers before beginning any mushroom-based regimen is essential!
What does the future hold for mushroom research in anxiety care?
As of 2025, research into mushrooms and anxiety is growing rapidly. Large-scale clinical trials are underway to better understand psilocybin’s efficacy and safety for anxiety disorders. At the same time, new formulations of functional mushroom extracts are being developed to standardize dosages and enhance therapeutic effects.
There is also exciting interest in combined protocols, such as pairing psilocybin therapy with Lion’s Mane supplementation, to harness the complementary benefits of both neuroplasticity and emotional breakthroughs. This integrated approach may represent the next frontier in personalized anxiety care.
Final thoughts
From everyday functional mushrooms like Lion's Mane and Reishi, to transformative psychedelic therapies, fungi are emerging as powerful allies in the fight against anxiety. As science continues to deepen our understanding, mushrooms offer a natural, holistic, and increasingly evidence-based path to emotional balance, resilience, and healing for millions seeking relief from anxiety.
Want to dive deeper?
References
World Health Organization. (2017). Depression and Other Common Mental Disorders: Global Health Estimates.
https://www.who.int/publications/i/item/depression-global-health-estimates
Nagano, M., et al. (2010). Reduction of depression and anxiety symptoms in menopausal women by Hericium erinaceus (Yamabushitake). Biomedical Research, 31(4), 231–237.
https://pubmed.ncbi.nlm.nih.gov/20834180/
Ratto, D., et al. (2021). Neuroprotective potential of Hericium erinaceus against oxidative stress and inflammation: implications for depression. Nutritional Neuroscience.
https://doi.org/10.1080/1028415X.2021.1972677
Tang, Y., et al. (2016). Ganoderma lucidum polysaccharides ameliorate anxiety-like behaviors in mice via anti-inflammatory mechanisms. International Journal of Molecular Sciences, 17(10), 1636.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000819/
Chen, X., et al. (2020). Reishi mushroom in functional foods and medicine: chemistry, bioactivities and health benefits. Food Hydrocolloids, 106198.
https://doi.org/10.1016/j.foodhyd.2020.106198
Kim, H.G., et al. (2015). Cordyceps militaris improves fatigue via modulation of oxidative stress and AMPK pathways in mice. Evidence-Based Complementary and Alternative Medicine, Article ID 354152.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553310/
Paterson, R.R. (2008). Cordyceps – a traditional Chinese medicine and another fungal therapeutic biofactory?Phytochemistry, 69(7), 1469–1495.
https://doi.org/10.1016/j.phytochem.2008.01.027
Ross, S., et al. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with cancer. Journal of Psychopharmacology, 30(12), 1165–1180.
https://pubmed.ncbi.nlm.nih.gov/27909164/
Agin-Liebes, G., et al. (2020). Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. Journal of Psychopharmacology, 34(2), 155–166.
https://pubmed.ncbi.nlm.nih.gov/32003974/
Davis, A.K., et al. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 78(5), 481–489.
https://pubmed.ncbi.nlm.nih.gov/33185213/
Gukasyan, N., et al. (2022). Psilocybin treatment for major depression: Extended follow-up and safety outcomes. Journal of Psychopharmacology, 36(1), 56–65.
https://doi.org/10.1177/02698811221079812
Reiff, C.M., et al. (2020). Psychedelics and psychedelic-assisted psychotherapy: Scientific, clinical, and legal issues. American Journal of Psychiatry, 177(5), 391–410.
https://doi.org/10.1176/appi.ajp.2019.19010035
Foster, J.A., et al. (2017). The microbiome and mental health: Hope or hype? Trends in Neurosciences, 40(5), 312–320.
https://doi.org/10.1016/j.tins.2016.10.006
Jiang, H., et al. (2015). Altered gut microbiota profile in patients with generalized anxiety disorder. Journal of Psychiatric Research, 63, 1–7.
https://pubmed.ncbi.nlm.nih.gov/25982938/